# A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults

> **NCT07172321** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** PF-08049820 MR1
- **DRUG:** PF-08049820 MR2
- **DRUG:** PF-08049820 IR

## Key facts

- **NCT ID:** NCT07172321
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-05
- **Primary completion:** 2025-10-04
- **Final completion:** 2025-10-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07172321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07172321, "A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07172321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*